Use of Therapeutic Pathogen Recognition Receptor Ligands for Osteo-Immunomodulation
Round 1
Reviewer 1 Report
The manuscript has quite improved from the previous submission.
Therefore I think it can be accepted in the present form.
Congratulations for the work improvement.
Reviewer 2 Report
All concerns have been addressed.
The manuscript is ready to publish.
Reviewer 3 Report
The authors of the paper “Use of Therapeutic Pathogen Recognition Receptor Ligands for Osteo-immunomodulation” aimed to explore the response of human mesenchymal stem cells (hMSCs) and monocytes-key cells in bone regeneration- towards therapeutic pathogen recognition receptor (PRR) ligand stimulation. Therefore they have evaluated the effect of various synthetic PRR ligands on bone cell differentiation and inflammation: alkaline phosphatase (ALP) activity in hMSCs, osteoclastogenic response induced in monocytes measured by TRAP, inflammatory property of ligands by ELISA evaluation of pro and anti–inflammatory (TNF-alpha, IL-6, IL-8, IL-10) cytokines expression. Based on the complex investigation, nucleic acid-based ligands Poly (I:C) and CpG ODN C were found to increase early ALP activity and not interfering with osteoclasts formation process. Their pro-osteogenic action was associated with a mild pro-inflammatory cell response. Due to these osteo-immunomodulatory effects, nucleic-acid ligands can be promising candidates for multifunctional coatings.
The new form is better presented.